1. Jacobs EM, Hartkamp A, Kaasjager HA. PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies. Neth J Med. 2003. 61:296–299.
2. DeGroot LJ, Jameson JL, Kretser D. Endocrinology. 2006. 5th ed. Saunders;2009–2010.
3. Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol. 2000. 142:587.
4. Lam DC, Lindsay RH. Accumulation of 2-14 Cpropylthiouracil in human polymorphonuclear leukocytes. Biochem Pharmacol. 1979. 28:2289–2296.
5. Jiang X, Khursigara G, Rubin RL. Transformation of lupus inducing drugs to cytotoxic products by activated neutrophils. Science. 1994. 266:810–813.
6. Wolf D, Ben-Yehuda A, Okon E, Naparstek Y. Nodular vasculitis associated with propylthiouracil therapy. Cutis. 1992. 49:253–255.
7. Choi HK, Merkel PA, Tervaert JW, Black RM, McCluskey RT, Niles JL. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegeners granulomatosis. Arthritis Rheum. 1999. 42:384–388.
8. Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y, Ito K. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol. 2001. 54:651–654.
9. Khurshid I, Sher J. Disseminated intravascular coagulation and vasculitis during propylthiouracil therapy. Postgrad Med J. 2000. 76:185–186.
10. Harper L, Cockwell P, Savage CO. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant. 1998. 13:455–458.
11. Chastain MA, Russo GG, Boh EE, Chastain JB, Falabella A, Millikan LE. Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature. J Am Acad Dermatol. 1999. 41:757–764.
12. Lee JC, Yoo B, Lim YJ, Kim SH, Lim M, Cho YS, Shong YK, Moon HB. A case of propylthiouracil-induced lupus. J Korean Rheum Assoc. 1999. 6:75–78.
13. Rhee Y, Chung SS, Nam SY, Song YD, Lim SK, Kim KR, Lee HC, Huh KB. A case of propylthiouracil induced anti-neutrophil cytoplasmic antibody (ANCA) positive vasculitis. J Korean Soc Endocrinol. 1999. 14:757–763.
14. Park YK, Yun YW, Sung SS, Park US, Park SH, Woo JH, Park JI, Jang SJ, Han SW, Oh YH, Park YW, Park MH, Kim HJ. Propylthiouracil-associated p-ANCA positive vasculitis with focal segmental glomerulosclerosis. Korean J Nephrol. 2004. 23:997–1003.
15. Kim JH, Kim HW, Jang EC, Jung WR, Ko SH, Shin YS, Park CW, Song KH, Choi YJ, Chang YS, Bang BK. A case of ANCA-positive crescentic glomerulonephritis after propylthiouracil treatment in Graves' disease. Korean J Nephrol. 2005. 24:305–312.
16. Lee SY, Jung JY, Lee KJ, Lee SH, Kim SJ, Lee EJ, Hur GY, Jung HC, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Yoo SH. A case of propylthiouracil induced diffuse pulmonary hemorrhage. Tuberc Respir Dis. 2005. 58:78–82.
17. Kim JW, Kim JS. A case of propylthiouracil-induced lupus erythematosus accompanied by antineutrophil cytoplasmic antibody-positive vasculitis. Korean J Dermatol. 2005. 43:496–500.